ArticleProstate cancer and prostatic diseases2023
Correction to: Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan.
Yu-Hsuan Joni Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.